-
EP1787639
European procedure
Extract from the Register of European Patents
EP About this file: EP1787639
| EP1787639 - Stable pharmaceutical solution formulations for pressurised metered dose inhalers [Right-click to bookmark this link] | Status | Opposition procedure closed Status updated on 10.02.2017 Database last updated on 31.08.2024 | Most recent event Tooltip | 10.02.2017 | Opposition procedure terminated - date of legal effect published | published on 15.03.2017 [2017/11] | Applicant(s) | For all designated states CHIESI FARMACEUTICI S.p.A. Via Palermo, 26/A 43100 Parma / IT | [2011/12] |
| Former [2007/21] | For all designated states CHIESI FARMACEUTICI S.p.A. Via Palermo, 26/A I-43100 Parma / IT | Inventor(s) | 01 /
Lewis, David Via Palermo, 26/A 43100 Parma / IT | 02 /
Ganderton, David Via Palermo, 26/A 43100 Parma / IT | 03 /
Meakin, Brian Via Palermo, 26/A 43100 Parma / IT | 04 /
Brambilla, Gaetano Via Palermo, 26/A 43100 Parma / IT | 05 /
Ferraris, Alessandra Via Palermo, 26/A 43100 Parma / IT | [2007/21] | Representative(s) | Dempster, Robert Charles, et al Maschio & Soames IP Limited 30 Carlton Crescent Southampton SO15 2EW / GB | [N/P] |
| Former [2007/21] | Adam, Holger Kraus & Weisert, Patent- und Rechtsanwälte, Thomas-Wimmer-Ring 15 80539 München / DE | Application number, filing date | 07004772.5 | 18.05.2001 | [2007/21] | Priority number, date | WO2000EP04635 | 22.05.2000 Original published format: PCT/EP00/04635 | [2007/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1787639 | Date: | 23.05.2007 | Language: | EN | [2007/21] | Type: | A3 Search report | No.: | EP1787639 | Date: | 25.02.2009 | [2009/09] | Type: | B1 Patent specification | No.: | EP1787639 | Date: | 23.03.2011 | Language: | EN | [2011/12] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 23.01.2009 | Classification | IPC: | A61K9/12, B65D83/14, A61K45/06, A61K31/57, A61K31/137, A61K31/4704 | [2009/09] | CPC: |
A61K9/008 (EP,US);
A61K9/12 (NO);
A61K31/167 (EP,US);
A61K31/439 (EP,US);
A61K31/4745 (EP,US);
A61K31/5386 (EP,US);
A61K31/56 (NO);
A61K31/573 (EP,US);
A61K45/06 (EP,US);
| C-Set: |
A61K31/167, A61K2300/00 (EP,US);
A61K31/439, A61K2300/00 (US,EP);
A61K31/5386, A61K2300/00 (US,EP);
A61K31/573, A61K2300/00 (US,EP) |
| Former IPC [2007/23] | A61K9/12, B65D83/14 | ||
| Former IPC [2007/21] | A61K9/12 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2007/21] | Extension states | AL | 23.07.2009 | LT | 23.07.2009 | LV | 23.07.2009 | MK | 23.07.2009 | RO | 23.07.2009 | SI | 23.07.2009 | Title | German: | Stabile pharmazeutische Lösungsformulierungen für unter Druck stehende Inhaliergeräte für die Verabreichung abgemessener Dosen | [2007/21] | English: | Stable pharmaceutical solution formulations for pressurised metered dose inhalers | [2007/21] | French: | Formulations de solutions pharmaceutiques stables pour inhalateurs à dosage mesuré pressurisés | [2007/21] | Examination procedure | 21.07.2009 | Amendment by applicant (claims and/or description) | 23.07.2009 | Examination requested [2009/36] | 18.08.2010 | Communication of intention to grant the patent | 17.12.2010 | Fee for grant paid | 17.12.2010 | Fee for publishing/printing paid | Parent application(s) Tooltip | EP01112230.6 / EP1157689 | Divisional application(s) | EP10166800.2 / EP2223682 | Opposition(s) | Opponent(s) | 01
21.12.2011
20.09.2016
WITHDRAWN Norton Healthcare Ltd Regent House 5-7 Broadhurst Gardens Swiss Cottage London NW6 3RZ / GB Opponent's representative Gillard, Richard Edward Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB | [2016/43] |
| Former [2012/06] | |||
| Opponent(s) | 01
21.12.2011
03.01.2012
ADMISSIBLE Norton Healthcare Ltd Regent House 5-7 Broadhurst Gardens Swiss Cottage London NW6 3RZ / GB Opponent's representative Gillard, Richard Edward Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB | 30.01.2012 | Invitation to proprietor to file observations on the notice of opposition | 08.10.2012 | Reply of patent proprietor to notice(s) of opposition | 16.10.2012 | Communication of observations of patent proprietor (Time limit: M04) | 04.02.2013 | Reply of parties involved to observations of patent proprietor | 21.09.2016 | Cancellation of oral proceeding that was planned for 23.09.2016 | 23.09.2016 | Date of oral proceedings | 29.09.2016 | Despatch of communication that the opposition procedure will be closed | 09.10.2016 | Legal effect of closure of opposition procedure [2017/11] | Fees paid | Renewal fee | 08.03.2007 | Renewal fee patent year 03 | 08.03.2007 | Renewal fee patent year 04 | 08.03.2007 | Renewal fee patent year 05 | 08.03.2007 | Renewal fee patent year 06 | 08.03.2007 | Renewal fee patent year 07 | 28.05.2008 | Renewal fee patent year 08 | 27.05.2009 | Renewal fee patent year 09 | 25.05.2010 | Renewal fee patent year 10 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US4499108 (SEQUEIRA JOEL A [US], et al) [A] 1 * column 1, line 5 - line 20; claim 1 *; | [DY]WO9413262 (JAGER PAUL D [US], et al) [DY] 1,5,7-11 * page 4, paragraph 4 - page 5, paragraph 1 * * page 5, paragraph L - page 6, paragraph 2 * * page 9, paragraph L - page 10, paragraph L * * page 12, paragraph L - page 15, paragraph L * * page 13; table 1 * * page 18; claim -; table 4 *; | [A]WO9632099 (GLAXO WELLCOME INC [US], et al) [A] 1-3 * page 2, line 12 - line 32 * * page 3, line 16 - line 25 * * page 5, line 6 - line 28 ** page 6, line 5 - line 19; example -; claims 1,2,11,14-17 *; | [XY]WO9965464 (BOEHRINGER INGELHEIM PHARMA [US]) [X] 1,5,9-11 * page 3, line 26 - page 5, line 2 * * page 5, line 27 - page 6, line 1 * * page 6, line 19 - page 7, line 2 * * page 7, line 10 - line L; examples 1,3; claims 1-5,8-10,14-17,20 * [Y] 1,5,7-11; | [A]WO0023065 (BOEHRINGER INGELHEIM PHARMA [DE], et al) [A] 1-10 * page 1, line 3 - line L * * page 2, paragraph 2 * * page 5, paragraph 3 - page 6, paragraph 1; example 3; claim 1 * |